STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
RMD RESMED INCORPORATED StockScouter® Report
5
StockScouter® Score
RESMED INCORPORATED, a large cap growth company in the healthcare sector, is expected to perform in line with the market over the next six months with less than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- The ratio of RMD’s forward price-to-earnings multiple to its estimated growth rate is below the average of comparably-sized companies in the StockScouter universe. Positive
- Shares are under accumulation by financial institutions. Marginally positive for large companies like RMD
Concerns
- The enterprise value-to-sales ratio is higher than the average for comparably-sized companies in the StockScouter universe. Negative
- One or more analysts has modestly decreased quarterly earnings estimates for RMD. Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that large cap stocks will be neutral, growth stocks will be out of favor, and healthcare stocks will be neutral.
Expected Risk/Return
Core Model Grades
C
D
D
C